PATENT CLAIM ANALYSIS

Application Number: 16229823
Application Type: Utility
Filing Date: 2018-12
Publication Date: 2019-05
Patent Classification: ["435", "325000"]

Abstract:
Disclosed are compositions comprising a non-homogenized chorionic matrix, a homogenized amniotic matrix and a homogenized UC (UC) matrix, wherein the non-homogenized chorionic matrix comprises viable cells. Disclosed are methods of making the compositions disclosed herein comprising preparing a non-homogenized chorionic matrix, preparing a homogenized amniotic matrix, preparing a homogenized UC matrix, and combining the non-homogenized chorionic matrix, the non-homogenized chorionic matrix, and the homogenized UC matrix. Disclosed are methods of treating a tissue injury or chronic pain comprising administering any of the disclosed compositions to an area of a subject comprising a tissue injury.

Claim (Index 65):
The composition of any one of  claims 47 - 64 , wherein the non-homogenized chorionic matrix and homogenized amniotic matrix are from the same donor.

Metadata:
- Claim Count in Document: 89.0
- Percentile: 98.0
- Lexical Diversity: 2.65
- Patent Class: 435.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15683868', '14291256', '15949808', '15274100', '14070040']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.5646836409760355
- 35 USC 102 Novelty (BERT): 0.5225428293787538
- Combined Prediction Score: 0.5604695598163073
- Mean Citation Score: 229.93502400000003
- Max Citation Score: 246.51277
- Similarity Product: 117.104958939541

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test